Andy M. Lawton

GlaxoSmithKline R&D
Middlesex, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Development of a reference material for analysing naturally occurring radioactive material from the steel industry.

Development of a reference material for analysing naturally occurring radioactive material from the steel industry.

Journal: Analytica chimica acta

Published: May 01, 2020

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.

Journal: Journal of neuroimmunology

Published: July 09, 2018

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.

Journal: PloS one

Published: June 16, 2016

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.

Journal: PloS one

Published: June 16, 2016

Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.

Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.

Journal: Regulatory toxicology and pharmacology : RTP

Published: January 20, 2016

Detecting Data Quality Issues in Clinical Trials: Current Practices and Recommendations.

Detecting Data Quality Issues in Clinical Trials: Current Practices and Recommendations.

Journal: Therapeutic innovation & regulatory science

Published: January 01, 2016

Designing and incorporating a real world data approach to international drug development and use: what the UK offers.

Designing and incorporating a real world data approach to international drug development and use: what the UK offers.

Journal: Drug discovery today

Published: May 13, 2015

Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials.

Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials.

Journal: Therapeutic innovation & regulatory science

Published: November 01, 2014

Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma's Approach, Part 1.

Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma's Approach, Part 1.

Journal: Therapeutic innovation & regulatory science

Published: September 01, 2014

Statistical approaches for conducting network meta-analysis in drug development.

Statistical approaches for conducting network meta-analysis in drug development.

Journal: Pharmaceutical statistics

Published: January 04, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026